Literature DB >> 17488069

Photobiological impact of [{(bpy)2Ru(dpp)}2RhCl2]Cl5 and [{(bpy)2Os(dpp)}2RhCl2]Cl5 [bpy=2,2'-bipyridine; dpp=2,3-Bis(2-pyridyl)pyrazine] on vero cells.

Alvin A Holder1, David F Zigler, Maria T Tarrago-Trani, Brian Storrie, Karen J Brewer.   

Abstract

The in vitro photobiology of the supramolecular complexes [{(bpy)2Ru(dpp)}2RhCl2]Cl5 and [{(bpy)2Os(dpp)}2RhCl2]Cl5 [bpy=2,2'-bipyridine; dpp=2,3-bis(2-pyridyl)pyrazine] with African green monkey kidney epithelial (Vero) cells was investigated. Previously, the complexes have been shown to photocleave DNA in the presence or absence of O2. Vero cell replication was uninhibited for cells exposed to the metal complex but protected from light. Vero cells that were exposed to metal complex, rinsed, and illuminated with >460 nm light showed a replication response that was metal complex concentration-dependent. Vero cells exposed to 3.0-120 microM [{(bpy)2Ru(dpp)}2RhCl2]Cl5 and illuminated showed inhibition of cell growth, with evidence of cell death seen for complex concentrations>or=10 microM. Cells exposed to [{(bpy)2Os(dpp)}2RhCl2]Cl5 at concentrations of 5.5-110 microM, rinsed, and illuminated showed only inhibition of cell growth. The impact of [{(bpy)2Ru(dpp)}2RhCl2]Cl5 and [{(bpy)2Os(dpp)}2RhCl2]Cl5 on cell growth following illumination shows the promise of this new structural motif as a photodynamic therapy agent.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17488069     DOI: 10.1021/ic0619916

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  9 in total

1.  Control and utilization of ruthenium and rhodium metal complex excited states for photoactivated cancer therapy.

Authors:  Jessica D Knoll; Claudia Turro
Journal:  Coord Chem Rev       Date:  2015-01-01       Impact factor: 22.315

2.  Photoactivated chemotherapy (PACT): the potential of excited-state d-block metals in medicine.

Authors:  Nicola J Farrer; Luca Salassa; Peter J Sadler
Journal:  Dalton Trans       Date:  2009-11-11       Impact factor: 4.390

3.  Panchromatic Osmium Complexes for Photodynamic Therapy: Solutions to Existing Problems and New Questions.

Authors:  Edith C Glazer
Journal:  Photochem Photobiol       Date:  2017-08-07       Impact factor: 3.421

4.  cis-Dichloridobis(1,10-phenanthroline)cobalt(II) dimethyl-formamide solvate.

Authors:  Shuang-Lian Cai; Shao-Ming Ying; Hui Li; Yun Chen
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2008-09-27

5.  Selective Photodissociation of Acetonitrile Ligands in Ruthenium Polypyridyl Complexes Studied by Density Functional Theory.

Authors:  Yi-Jung Tu; Shivnath Mazumder; John F Endicott; Claudia Turro; Jeremy J Kodanko; H Bernhard Schlegel
Journal:  Inorg Chem       Date:  2015-08-05       Impact factor: 5.165

6.  Transition Metal Complexes and Photodynamic Therapy from a Tumor-Centered Approach: Challenges, Opportunities, and Highlights from the Development of TLD1433.

Authors:  Susan Monro; Katsuya L Colón; Huimin Yin; John Roque; Prathyusha Konda; Shashi Gujar; Randolph P Thummel; Lothar Lilge; Colin G Cameron; Sherri A McFarland
Journal:  Chem Rev       Date:  2018-10-08       Impact factor: 60.622

7.  Preliminary anti-cancer photodynamic therapeutic in vitro studies with mixed-metal binuclear ruthenium(II)-vanadium(IV) complexes.

Authors:  Alvin A Holder; Patrick Taylor; Anthony R Magnusen; Erick T Moffett; Kyle Meyer; Yiling Hong; Stuart E Ramsdale; Michelle Gordon; Javelyn Stubbs; Luke A Seymour; Dhiraj Acharya; Ralph T Weber; Paul F Smith; G Charles Dismukes; Ping Ji; Laura Menocal; Fengwei Bai; Jennie L Williams; Donald M Cropek; William L Jarrett
Journal:  Dalton Trans       Date:  2013-09-07       Impact factor: 4.390

8.  Bis[pyrrolyl Ru(ii)] triads: a new class of photosensitizers for metal-organic photodynamic therapy.

Authors:  Deborah A Smithen; Susan Monro; Mitch Pinto; John Roque; Roberto M Diaz-Rodriguez; Huimin Yin; Colin G Cameron; Alison Thompson; Sherri A McFarland
Journal:  Chem Sci       Date:  2020-10-06       Impact factor: 9.825

9.  Combination of Ru(ii) complexes and light: new frontiers in cancer therapy.

Authors:  Cristina Mari; Vanessa Pierroz; Stefano Ferrari; Gilles Gasser
Journal:  Chem Sci       Date:  2015-01-13       Impact factor: 9.825

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.